2-Butyl-4-Chloro-5-Formylimidazole (BCFI) CAS 83857-96-9 Losartan Potassium Intermediate Factory
Ipese Potasiomu Losartan ati Awọn agbedemeji ibatan
Losartan Potasiomu CAS 124750-99-8
2-Butyl-4-Chloro-5-Formylimidazole (BCFI) CAS 83857-96-9
Didara to gaju, iṣelọpọ Iṣowo
Orukọ Kemikali | 2-Butyl-4-chloro-5-formylimidazole |
Awọn itumọ ọrọ sisọ | BCFI;2-Butyl-5-chloro-1H-imidazole-4-carboxaldehyde |
Nọmba CAS | 83857-96-9 |
NỌMBA CAT | RF-PI319 |
Iṣura Ipo | Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu |
Fọọmu Molecular | C8H11ClN2O |
Òṣuwọn Molikula | 186.64 |
iwuwo | 1.240 |
Solubility | Soluble ni kẹmika ati Chloroform;Die-die tiotuka ninu Omi |
Brand | Ruifu Kemikali |
Nkan | Awọn pato |
Ifarahan | Ina Yellow to Yellow Crystalline Powder |
Idanimọ | Gbọdọ ni ibamu si Iwọn Itọkasi |
Ojuami Iyo | 96.0 ~ 99.0 ℃ (tan.) |
Akoonu Ọrinrin (KF) | ≤0.50% |
Imidazolol | Ko ṣe awari |
Valeronitile | ≤0.15% |
Idọti nikan | ≤0.15% |
Lapapọ aimọ | ≤1.0% |
Mimọ / Analysis Ọna | ≥99.0% (nipasẹ HPLC) |
Igbeyewo Standard | Standard Enterprise |
Lilo | Agbedemeji ti Potasiomu Losartan (CAS 124750-99-8) Antihypertensive |
Package: Igo, apo apamọwọ Aluminiomu, ilu paali, 25kg / Drum, tabi gẹgẹbi ibeere alabara.
Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin.
2-Butyl-4-chloro-5-formylimidazole (BCFI) (CAS 83857-96-9) jẹ agbedemeji ti Losartan Potassium (CAS 124750-99-8), antagonist olugba angiotensin II.Potasiomu Losartan jẹ iyọ potasiomu ti losartan pẹlu iṣẹ ṣiṣe antihypertensive, eyiti a lo ni pataki ni itọju ti titẹ ẹjẹ giga (haipatensonu) ati nephropathy dayabetik.O ṣiṣẹ nipa sisẹ awọn ohun elo ẹjẹ ki ẹjẹ le san diẹ sii ni irọrun.O tun munadoko lati ṣe iranlọwọ lati daabobo awọn kidinrin lati ibajẹ ti o fa nipasẹ àtọgbẹ ati dinku awọn eewu ti ọpọlọ ni awọn alaisan ti o ni haipatensonu ati imugboroja myocardial.Yato si, iwadi aipẹ ti daba pe losartan jẹ anfani lati yiyipada aiṣedeede ti o ni ibatan ọjọ-ori ni mimu titẹ ẹjẹ deede ati lilo agbara cellular lori mitochondria ati pe o le ṣee lo lati tọju hypertrophy ventricular osi.